The Neuropathology core provides complete brain banking and neuropathology diagnostic services for the Pittsburgh ADRC. To assure banking of excellent quality tissues with short post-mortem times, autopsies arc performed on a 24 hour basis. The brain is bisected sagittally at the time of autopsy. The right half is dissected for distribution to ADRC investigators and flash-frozen banking. The left half of the brain is fixed and made available for magnetic resonance imaging. After fixation the left hemi-brain is extensively sampled for neuropathology diagnostic tests including H&E, Congo Red, immunocytochemical and silver stains. Microscopic analysis of the left hemi-brain is performed according to a modification of the revised CERAD protocol. In addition to the differential diagnostics for neurodegenerative diseases, those brains found to possess changes of Alzheimer's Disease are staged according to published criteria of tangle densities. The brain bank is catalogued and correlated with neuropathology diagnoses to make available well characterized tissues to ADRC and other investigators. Neuropathology diagnoses are supplied to the ADRC database and families within one month of death. As of 1993 the neuropathology core banks approximately 50 ADRC autopsies per year. Additionally 100 control brains will be banked and characterized by routine gross and microscopic neuropathologic examination. The core maintains a reference laboratory (including a Ar/Kr laser confocal microscope and workstation) for development of detailed and quantitative analyses.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005133-13
Application #
5204449
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1996
Total Cost
Indirect Cost
Besser, Lilah M; Kukull, Walter A; Teylan, Merilee A et al. (2018) The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses. J Neuropathol Exp Neurol 77:717-726
Lingler, Jennifer H; Roberts, J Scott; Kim, Hyejin et al. (2018) Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure. Alzheimers Dement (Amst) 10:413-420
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Krivinko, Josh M; Erickson, Susan L; Ding, Ying et al. (2018) Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease. Am J Psychiatry 175:999-1009
Lancour, Daniel; Naj, Adam; Mayeux, Richard et al. (2018) One for all and all for One: Improving replication of genetic studies through network diffusion. PLoS Genet 14:e1007306
Tudorascu, Dana L; Minhas, Davneet S; Lao, Patrick J et al. (2018) The use of Centiloids for applying [11C]PiB classification cutoffs across region-of-interest delineation methods. Alzheimers Dement (Amst) 10:332-339
DeKosky, Steven T; Jaffee, Michael; Bauer, Russell (2018) Long-term Mortality in NFL Professional Football Players: No Significant Increase, but Questions Remain. JAMA 319:773-775
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Snitz, Beth E; Wang, Tianxiu; Cloonan, Yona Keich et al. (2018) Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting. Alzheimers Dement 14:734-742

Showing the most recent 10 out of 667 publications